Pay in 4 interest-free payments of $5.87 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Its molecular weight (4,845.44 g/mol) and formula (CHNO) sit close to tirzepatide's, but its receptor-engagement profile is distinct
This explains why these breakthrough medications are so popular among doctors and patients
FGF21 is produced primarily in the liver in response to metabolic stress and acts as a systemic regulator of energy balance stimulating fatty acid oxidation, promoting adiponectin secretion, and supporting healthy mitochondrial function in brown adipose tissue.* FGF21 levels are closely correlated with metabolic flexibility the ability of cells to switch efficiently between fuel sources
T2DM: Type 2 Diabetes Mellitus Industry-sponsored trials are actively underway (or have already been completed) exploring the potential for GLP-1 based therapies in a range of new indications
Tirzepatide is a dual GIP and GLP-1 receptor agonist , meaning it works by activating two important hormonal pathways in the body: the Glucose-dependent Insulinotropic Polypeptide (GIP) receptor and the Glucagon-like Peptide-1 (GLP-1) receptor
US$ 26.80
US$ 25.02
US$ 22.20
US$ 20.14
US$ 24.63
US$ 22.14
US$ 24.74
